Other
Exp Group
Exp Group is an intervention with 2 clinical trials. Currently 2 active trials ongoing.
Total Trials
2
Max Phase
—
Type
COMBINATION PRODUCT
Molecule
—
Success Metrics
Active Trials
2(100%)
Phase Distribution
Ph not_applicable
2
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
2
all time
Status Distribution
Active(2)
Detailed Status
Active, not recruiting2
Development Timeline
Analytics
Development Status
Total Trials
2
Active
2
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
active_not_recruiting2100%
Recent Activity
2 active trials
Showing 2 of 2
active_not_recruitingnot_applicable
Comparison of Binocular Spectacle Prescription Versus Patching Therapy in Refractive Amblyopia Patients
NCT06739798
active_not_recruitingnot_applicable
Effect of Virtual BASRD Reality Training Versus Conservative Treatment In Chronic Hemipretic Stroke Survivors
NCT06582394
Clinical Trials (2)
Showing 2 of 2 trials
NCT06739798Not Applicable
Comparison of Binocular Spectacle Prescription Versus Patching Therapy in Refractive Amblyopia Patients
NCT06582394Not Applicable
Effect of Virtual BASRD Reality Training Versus Conservative Treatment In Chronic Hemipretic Stroke Survivors
All 2 trials loaded
Drug Details
- Intervention Type
- COMBINATION PRODUCT
- Total Trials
- 2